Tezepelumab in Real-World U.S. Patients with Severe Asthma Across Phenotypes and Underrepresented Populations: The Phase 4 PASSAGE Study.
Saved in:
| Title: | Tezepelumab in Real-World U.S. Patients with Severe Asthma Across Phenotypes and Underrepresented Populations: The Phase 4 PASSAGE Study. |
|---|---|
| Authors: | Lugogo NL; Department of Medicine, Division of Pulmonary and Critical Care Medicine, University of Michigan, Ann Arbor, MI., Akuthota P; Division of Pulmonary, Critical Care and Sleep Medicine, University of California San Diego, La Jolla, CA., Sumino K; Department of Medicine, Division of Pulmonary and Critical Care Medicine, Washington University School of Medicine, St Louis, MO., Burnette AF; Division of Allergy and Immunology, Howard University, Washington, D.C., Mathur SK; Department of Medicine, Division of Allergy, Pulmonary and Critical Care Medicine, University of Wisconsin-Madison, Madison, WI., Lindsley AW; U.S. Medical Affairs, Amgen, Thousand Oaks, CA., Llanos JP; Global Medical Affairs, Amgen, Thousand Oaks, CA., Marchese C; Respiratory and Immunology, BioPharmaceuticals R&D, AstraZeneca, Barcelona, Spain., Ambrose CS; Respiratory and Immunology, BioPharmaceuticals Medical, AstraZeneca, Gaithersburg, MD., Emmanuel B; Respiratory and Immunology, BioPharmaceuticals Medical, AstraZeneca, Gaithersburg, MD. |
| Source: | American journal of respiratory and critical care medicine [Am J Respir Crit Care Med] 2026 May 18. Date of Electronic Publication: 2026 May 18. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: American Thoracic Society Country of Publication: England NLM ID: 9421642 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1535-4970 (Electronic) Linking ISSN: 1073449X NLM ISO Abbreviation: Am J Respir Crit Care Med Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 42148905 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Tezepelumab in Real-World U.S. Patients with Severe Asthma Across Phenotypes and Underrepresented Populations: The Phase 4 PASSAGE Study. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Lugogo+NL%22">Lugogo NL</searchLink>; Department of Medicine, Division of Pulmonary and Critical Care Medicine, University of Michigan, Ann Arbor, MI.<br /><searchLink fieldCode="AU" term="%22Akuthota+P%22">Akuthota P</searchLink>; Division of Pulmonary, Critical Care and Sleep Medicine, University of California San Diego, La Jolla, CA.<br /><searchLink fieldCode="AU" term="%22Sumino+K%22">Sumino K</searchLink>; Department of Medicine, Division of Pulmonary and Critical Care Medicine, Washington University School of Medicine, St Louis, MO.<br /><searchLink fieldCode="AU" term="%22Burnette+AF%22">Burnette AF</searchLink>; Division of Allergy and Immunology, Howard University, Washington, D.C.<br /><searchLink fieldCode="AU" term="%22Mathur+SK%22">Mathur SK</searchLink>; Department of Medicine, Division of Allergy, Pulmonary and Critical Care Medicine, University of Wisconsin-Madison, Madison, WI.<br /><searchLink fieldCode="AU" term="%22Lindsley+AW%22">Lindsley AW</searchLink>; U.S. Medical Affairs, Amgen, Thousand Oaks, CA.<br /><searchLink fieldCode="AU" term="%22Llanos+JP%22">Llanos JP</searchLink>; Global Medical Affairs, Amgen, Thousand Oaks, CA.<br /><searchLink fieldCode="AU" term="%22Marchese+C%22">Marchese C</searchLink>; Respiratory and Immunology, BioPharmaceuticals R&D, AstraZeneca, Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Ambrose+CS%22">Ambrose CS</searchLink>; Respiratory and Immunology, BioPharmaceuticals Medical, AstraZeneca, Gaithersburg, MD.<br /><searchLink fieldCode="AU" term="%22Emmanuel+B%22">Emmanuel B</searchLink>; Respiratory and Immunology, BioPharmaceuticals Medical, AstraZeneca, Gaithersburg, MD. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%229421642%22">American journal of respiratory and critical care medicine</searchLink> [Am J Respir Crit Care Med] 2026 May 18. <i>Date of Electronic Publication: </i>2026 May 18. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22American+Thoracic+Society%22">American Thoracic Society </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>9421642 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1535-4970 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%221073449X%22">1073449X </searchLink><i>NLM ISO Abbreviation: </i>Am J Respir Crit Care Med <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=42148905 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1093/ajrccm/aamag225 Languages: – Code: eng Text: English Titles: – TitleFull: Tezepelumab in Real-World U.S. Patients with Severe Asthma Across Phenotypes and Underrepresented Populations: The Phase 4 PASSAGE Study. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Lugogo NL – PersonEntity: Name: NameFull: Akuthota P – PersonEntity: Name: NameFull: Sumino K – PersonEntity: Name: NameFull: Burnette AF – PersonEntity: Name: NameFull: Mathur SK – PersonEntity: Name: NameFull: Lindsley AW – PersonEntity: Name: NameFull: Llanos JP – PersonEntity: Name: NameFull: Marchese C – PersonEntity: Name: NameFull: Ambrose CS – PersonEntity: Name: NameFull: Emmanuel B IsPartOfRelationships: – BibEntity: Dates: – D: 18 M: 05 Text: 2026 May 18 Type: published Y: 2026 Identifiers: – Type: issn-electronic Value: 1535-4970 Titles: – TitleFull: American journal of respiratory and critical care medicine Type: main |
| ResultId | 1 |
